Table 1:

Time-dependent effect of CAF chemotherapy on markers of antioxidant activity in breast cancer patients. Values are expressed as Mean ± SD.

		n	r-SOD (U/g Hb)	r-CAT (U/g Hb)	r-GPx (U/g Hb)	FRAP (mEq)
I	Control	20	297.67± 39.29	3010.90 ± 746.52	7.84 ± 1.04	782.60 ± 112.08
II	Day 0 (Baseline)	55	323.54± 43.34	4287.65 ± 737.49a	7.78 ± 1.01	819.98 ± 110.75
III	12 weeks from baseline	55	249.08± 54.31a,b	3348.04± 842.79c	6.49 ± 1.18d,e	657.30 ± 100.68b,f
IV	18 weeks from baseline	35	252.72 ± 49.83b,f	3360.85± 835.54c	6.41 ± 1.22d,e	641.37± 95.99b,e
V	26 weeks from baseline	35	240.06 ± 49.69b,e	3350.36± 835.87c	6.26 ± 1.21b,e	630.75± 95.99b,e

^aP < 0.05 vs. control

^bP < 0.001 vs. baseline

^cP < 0.001 vs. baseline

^dP < 0.001 vs. baseline

^eP < 0.001 vs. control

^fP < 0.01 vs. control